|
Volumn 12, Issue 1, 2003, Pages 75-78
|
Pulmonary vein ablation for atrial fibrillation: When should this be the treatment of choice?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIGOXIN;
FLECAINIDE;
PROPAFENONE;
SOTALOL;
WARFARIN;
BLEEDING;
BLEEDING TENDENCY;
CATHETER ABLATION;
DRUG SAFETY;
DRUG WITHDRAWAL;
HEART ATRIUM FIBRILLATION;
HUMAN;
MEDICAL DECISION MAKING;
PATHOPHYSIOLOGY;
RECURRENT DISEASE;
REVIEW;
SIDE EFFECT;
STROKE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
|
EID: 0037221982
PISSN: 10621458
EISSN: None
Source Type: Journal
DOI: 10.1016/S1062-1458(02)01085-1 Document Type: Review |
Times cited : (4)
|
References (10)
|